Manufacturer record
Unicure India Ltd. C-21: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
7 batches manufactured by Unicure India Ltd. C-21 (Uttar Pradesh) were declared Not of Standard Quality between August 2019 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
7 records linked to Unicure India Ltd. C-21 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Aspirin Gastro-resistant Tablets IP 75 mg. | ANET1295Mfg 2024-12 · Exp 2026-11 | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution in Acid stage for Aspirin.Dissolution | RDTL, GuwahatiCDSCO lab | Feb 2026 |
| Paracetamol Tablets IP 500mg | PCT1211Mfg 2024-08 · Exp 2026-07 | The sample does not confirm to IP2022 requirement withespect to Dissolution TestDissolution | DTL,Dalgate Srinagar Kashmir( J and K)State lab | Jan 2026 |
| Vildagliptin and Metformin Tablets IP | VMHT1315Mfg 2025-05 · Exp 2027-04 | The sample received does not conform to I.P. 2022 with respect to Assay and Dissolution.Assay | CDTL, MumbaiCDSCO lab | Dec 2025 |
| Paracetamol Tablets I.P. (500 mg) | PCT1210Mfg 2024-08 · Exp 2026-07 | The sample does not conform to I.P with respect to the test for Dissolution.Dissolution | CDTL, IndoreCDSCO lab | Oct 2025 |
| Norfloxacin Tablets IP 400 mg | NT-802Mfg 2020-10 · Exp 2022-09 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Jul 2021 |
| Norfloxacin Tablet I.P. 400 mg. | NT603Mfg 2019-02 · Exp 2021-01 | DissolutionDissolution | RDTL GuwahatiState lab | Sep 2019 |
| Norfloxacin Tablets I.P. 400 mg | NT606Mfg 2019-02 · Exp 2021-01 | DissolutionDissolution | RDTL GuwahatiState lab | Aug 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.